 |
|
Genetic and Environmental Influences in the Development of Multiple Primary Melanoma
A. David Burden, MD, MRCP;
John Newell, MSc;
Nicola Andrew, MSc;
Gina Kavanagh, MB, MRCP;
J. Michael Connor, MD, FRCP;
Rona M. MacKie, MD, FRCP
Arch Dermatol. 1999;135:261-265.
Objectives To identify risk factors and the prognosis associated with the development of multiple primary melanoma (MPM).
Design Case-comparison studies of subjects with MPM and single primary melanoma. Sequencing of CDKN2A in germline DNA.
Setting Population-based study of patients with invasive melanoma in Scotland between 1979 and 1996.
Patients For mortality studies, 108 patients with MPM and 216 single melanoma controls matched for age, sex, site, and tumor thickness. For risk factor studies, 48 patients with MPM and 48 single melanoma controls matched as above. For CDKN2A analysis, a sample of 23 subjects with MPM.
Results The development of MPM was found not to be an independent prognostic factor. The risk of MPM was greatest in those with a family history of melanoma, with large numbers of benign nevi, and the presence of clinically or histologically atypical nevi. Germline mutations of CDKN2A were present in 6 of 23 patients with MPM and in 5 cases consisted of the base pair substitution Met53Ile.
Conclusions The importance of MPM should be addressed in melanoma follow-up protocols. Those patients at greatest risk can be identified by a family history of melanoma and their mole pattern. Germline mutations in CDKN2A occur in both familial and sporadic MPM and further studies are required to determine the value of analysis of this gene in melanoma surveillance. Patients should be informed that the development of MPM does not adversely affect their prognosis.
From the Departments of Dermatology (Drs Burden and MacKie), Statistics (Mr Newell), and Medical Genetics (Ms Andrew and Dr Connor), University of Glasgow, Glasgow, and the Department of Dermatology, Royal Infirmary of Edinburgh, Edinburgh (Dr Kavanagh), Scotland.
RELATED ARTICLES
Multiple Primary Melanoma Is Not a Distinct Biological Entity
Jean-Jacques Grob
Arch Dermatol. 1999;135(3):325-327.
EXTRACT
| FULL TEXT
Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 1999;135(3):358-359.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Treatment of Atypical Nevi With Imiquimod 5% Cream
Somani et al.
Arch Dermatol 2007;143:379-385.
ABSTRACT
| FULL TEXT
Multiple primary melanoma: two-year results from a population-based study.
Titus-Ernstoff et al.
Arch Dermatol 2006;142:433-438.
ABSTRACT
| FULL TEXT
Population-Based Analysis of Prognostic Factors and Survival in Familial Melanoma
Florell et al.
JCO 2005;23:7168-7177.
ABSTRACT
| FULL TEXT
Dysplastic Nevi
Naeyaert and Brochez
NEJM 2003;349:2233-2240.
FULL TEXT
Enhanced Survival in Patients With Multiple Primary Melanoma
Doubrovsky and Menzies
Arch Dermatol 2003;139:1013-1018.
ABSTRACT
| FULL TEXT
Multiple Primary Melanoma Is Not a Distinct Biological Entity
Grob
Arch Dermatol 1999;135:325-327.
FULL TEXT
|
